Sodium Chloride Injection — Class II drug recall D-813-2013
Terminated recall by Hospira Inc., reported 2013-07-31, distributed nationwide. Presence of Particulate Matter: Confirmed customer report of visible particulate in the form of an orange or r
| Recall number | D-813-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira Inc., Lake Forest, IL, United States |
| Recall initiated | 2013-06-27 |
| Classified | 2013-07-22 |
| Reported by FDA | 2013-07-31 |
| Terminated | 2015-06-04 |
| Distributed | Nationwide (US) |
| Quantity | 268,700 vials |
| Reason classes | specification failure |
| NDC | 00409-1918, 00409-1918-32, 00409-1918-33, 00409-1918-35, 00409-1918-42, 00409-1918-43, 00409-1918-45, 00409-4888, 00409-4888-01, 00409-4888-02, 00409-4888-03, 00409-4888-06, 00409-4888-10, 00409-4888-12, 00409-4888-20, 00409-4888-50, 00409-4888-90 |
| Expiration dates | 2014-03-01 |
Product
Sodium Chloride Injection, USP, 0.9%, 20 mL Single-dose Fliptop Plastic Vial, packaged in 25 vial Units per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-4888-20.
Reason for recall
Presence of Particulate Matter: Confirmed customer report of visible particulate in the form of an orange or rust colored ring embedded in between the plastic layers of the plastic vial.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-813-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.